Reber Genetics is committed to developing innovative and high-quality animal vaccines and applying human cancer immunotherapy to the treatment of animal diseases
Reber Genetics adheres to innovative research and development and the pursuit of high-quality products as its main business purposes, seeks technical cooperation with industry, academia, and industry with an open attitude, and uses diversified business models to develop domestic and foreign markets.
At the same time, Reber Genetics has an excellent sales team and strong distribution channels, as well as factory equipment that meets PICS/GMP specifications. It can produce high-quality products that meet international standards and hopes to move towards a leading brand of animal vaccines in the future.
At the same time, Reber Genetics has an excellent sales team and strong distribution channels, as well as factory equipment that meets PICS/GMP specifications. It can produce high-quality products that meet international standards and hopes to move towards a leading brand of animal vaccines in the future.
